SS
Stefania Stucci
physics.ins-detabemaciclibbreast cancerBreast cancerBreast Neoplasmsdrug–drug interactionsDrug-drug interactionshep-exPFSprogression-free survival
On Valency
published · living versionsW_mjcvd2u3·v1 · currentpublished
Ultra-Fast 4H-SiC AC-LGAD for 4D Tracking Applications
with Tao Yang, Chengxi Yang, Ben J. Sekely, Yashas Satapathy +10
1 version
Preprints & journals
4 papers in the corpus · 2022–2026Ultra-Fast 4H-SiC AC-LGAD for 4D Tracking Applications2610.27535v1 · Tao Yang, Chengxi Yang, Ben J. Sekely et al.2026 · 0 citationsarXivon Valency
The administration of proton pump inhibitors with the CDK4/6 inhibitor abemaciclib does not affect the clinical outcome of metastatic breast cancer patients.42051387 · Crucitta, Stefania, Cinacchi, Paola, Bargagna, Irene et al.2026 · 0 citationsTherapeutic advances in drug safety. 2026;17:20420986251414591
Time Resolution Characterization of 4H-SiC LGADs with a Sr Source2509.04638v1 · Tao Yang, Yashas Satapathy, Ben J. Sekely et al.2025 · 0 citationsarXiv
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib.36283134 · Del Re, Marzia, Crucitta, Stefania, Omarini, Claudia et al.2022 · 23 citationsBreast (Edinburgh, Scotland). 2022;66:157-161
Career total: 6 works. 4 are in this corpus.
Profile built from the corpus for this byline.
Author records are still filling in while the Hub is in alpha. If this is your page, you'll be able to claim it soon. Spot a mistake? Tell us.